Table 7.
Variables | Coefficient | 95% CI | P-value | |
---|---|---|---|---|
Age (years) | −0.01 | −0.04 | 0.03 | 0.78 |
SBP (mmHg) | 0.00 | −0.01 | 0.02 | 0.87 |
DBP (mmHg) | −0.02 | −0.04 | 0.00 | 0.02 |
BMI (kg/m2) | 0.02 | −0.02 | 0.05 | 0.35 |
Duration of disease (years) | 0.01 | −0.02 | 0.03 | 0.56 |
Sex | ||||
Female=0 | ||||
Male=1 | 0.36 | −0.02 | 0.75 | 0.07 |
Marital status | ||||
Single, divorced, or widowed=0 | ||||
Married or living together=1 | −0.46 | −1.02 | 0.10 | 0.11 |
Education | ||||
Primary or none=1 | ||||
Secondary, vocational or higher=1 | −0.31 | −0.76 | 0.14 | 0.18 |
Occupational activity | ||||
Employed or annuitant=0 | ||||
Retired=1 | −0.44 | −0.84 | −0.04 | 0.03 |
Living arrangement | ||||
Living alone or in an organized institution=0 | ||||
Living with family=1 | 0.34 | −0.17 | 0.85 | 0.19 |
JNC classification of HT | ||||
Prehypertension=0 | ||||
Stage I or II HT=1 | 0.44 | −0.05 | 0.93 | 0.08 |
Smoking | ||||
Non-smoker=0 | ||||
Smoker or ex-smoker=1 | −0.18 | −0.61 | 0.25 | 0.42 |
Alcohol | ||||
Abstinent=0 | ||||
Non-abstinent=1 | 0.29 | −0.14 | 0.71 | 0.19 |
Diabetes | ||||
No=0 | ||||
Yes=1 | 0.34 | −0.04 | 0.72 | 0.08 |
Hypercholesterolemia | ||||
No=0 | ||||
Yes=1 | 0.27 | −0.14 | 0.68 | 0.19 |
Coronary artery disease | ||||
No=0 | ||||
Yes=1 | 0.17 | −0.31 | 0.65 | 0.49 |
Renal failure | ||||
No=0 | ||||
Yes=1 | −0.18 | −0.74 | 0.38 | 0.53 |
Rheumatic diseases | ||||
No=0 | ||||
Yes=1 | 0.13 | −0.37 | 0.63 | 0.61 |
Alpha-adrenolytic | ||||
No=0 | ||||
Yes=1 | −0.01 | −0.48 | 0.46 | 0.97 |
BA | ||||
No=0 | ||||
Yes=1 | 0.26 | −0.74 | 1.25 | 0.61 |
CCB | ||||
No=0 | ||||
Yes=1 | 0.27 | −0.22 | 0.77 | 0.28 |
ARB | ||||
No=0 | ||||
Yes=1 | 0.52 | −0.04 | 1.09 | 0.07 |
TD | ||||
No=0 | ||||
Yes=1 | 0.23 | −0.68 | 1.14 | 0.62 |
ACEI | ||||
No=0 | ||||
Yes=1 | 0.65 | 0.11 | 1.20 | 0.02 |
Therapy | ||||
Monotherapy=0 | ||||
Polytherapy=1 | 0.10 | −0.46 | 0.67 | 0.72 |
Note: P, level of statistical significance.
Abbreviations: AA, alpha-adrenolytic; ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin receptor blocker; BA, beta-adrenolytic; BMI, body mass index; CCB, calcium channel blocker; Hill-Bone CHBPTS, Hill-Bone Compliance to High Blood Pressure Therapy Scale; HT, hypertension; JNC, Joint National Committee; TD, thiazide diuretic.